Search results
Results from the WOW.Com Content Network
IL13RA2+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Overview of all the structural information available in the PDB for UniProt: Q14627 (Interleukin-13 receptor subunit alpha-2) at the PDBe-KB. This article incorporates text from the United States National Library of Medicine, which is in the public ...
There is also another receptor that can bind IL-13: IL-13Rα2 encoded by the IL13RA2 gene. This binds IL-13 with very high affinity (and can therefore sequester it) but does not allow IL-4 binding. It acts as a negative regulator of both IL-13 and IL-4, however the mechanism of this is still undetermined. [3]
IL13RA2 - Interleukin-13 receptor subunit alpha-2 CD214 not assigned CD215: IL15RA - Interleukin 15 receptor, alpha subunit CD216 not assigned CD217: IL17R - Interleukin-17 receptor; a cytokine receptor which binds interleukin 17A. CD218a: IL18R1 - interleukin-18 receptor 1 CD218b: IL18RAP - Interleukin 18 receptor accessory protein.
Type II cytokine receptors, also commonly known as class II cytokine receptors, are transmembrane proteins that are expressed on the surface of certain cells. They bind and respond to a select group of cytokines including interferon type I, interferon type II, interferon type III.
The diagnosis of TRAPS may show an increased IgD level in a possibly affected individual, other methods to ascertain a definite finding is via the following: [3] [4] Blood test; Genetic test; Clinical evaluation
Calpainopathy is the most common type of autosomal recessive limb-girdle muscular dystrophy (LGMD). [2] It preferentially affects the muscles of the hip girdle and shoulder girdle.
13q deletion syndrome is a rare genetic disease caused by the deletion of some or all of the large arm of human chromosome 13.Depending upon the size and location of the deletion on chromosome 13, the physical and mental manifestations will vary.
The differential diagnosis of glycogen storage disease type III includes GSD I, GSD IX and GSD VI. This however does not mean other glycogen storage diseases should not be distinguished as well. This however does not mean other glycogen storage diseases should not be distinguished as well.